| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.3M | -54.9% |
| Cost of Revenue | $9.5M | -25.3% |
| Gross Profit | -$3.2M | -340.2% |
| R&D Expense | $646K | -16.2% |
| SG&A Expense | $3.4M | -14.0% |
| Operating Income | -$8.4M | -92.5% |
| Net Income | -$9.1M | -95.3% |
| EPS (Basic) | -$3.59 | -93.0% |
| EPS (Diluted) | -$3.59 | -93.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $200K | -59.8% |
| Accounts Receivable | $330K | -84.7% |
| Inventory | $9.4M | -26.9% |
| Current Assets | $10.0M | -35.7% |
| Total Assets | $10.4M | -40.5% |
| Current Liabilities | $10.3M | +20.2% |
| Total Liabilities | $10.3M | +13.9% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.1M | -97.9% |
| Capital Expenditures | $19K | +0.0% |
| Investing Cash Flow | -$19K | +0.0% |
| Financing Cash Flow | $763K | +51.4% |
| Free Cash Flow | -$1.1M | -94.6% |
| $144K |
| -98.3% |